Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1983 1
1984 1
1985 1
1986 1
1987 3
1988 1
1989 2
1990 1
1992 1
1993 2
1994 4
1995 4
1996 2
1997 2
1998 3
1999 2
2000 1
2002 1
2003 4
2004 1
2005 3
2006 5
2007 2
2008 2
2009 1
2010 5
2011 15
2012 17
2013 2
2015 4
2016 4
2017 1
2020 1
2021 0
Text availability
Article attribute
Article type
Publication date

Search Results

87 results
Results by year
Filters applied: . Clear all
Page 1
Structure-Based Drug Discovery of N-((R)-3-(7-Methyl-1H-indazol-5-yl)-1-oxo-1-(((S)-1-oxo-3-(piperidin-4-yl)-1-(4-(pyridin-4-yl)piperazin-1-yl)propan-2-yl)amino)propan-2-yl)-2'-oxo-1',2'-dihydrospiro[piperidine-4,4'-pyrido[2,3-d][1,3]oxazine]-1-carboxamide (HTL22562): A Calcitonin Gene-Related Peptide Receptor Antagonist for Acute Treatment of Migraine.
Bucknell SJ, Ator MA, Brown AJH, Brown J, Cansfield AD, Cansfield JE, Christopher JA, Congreve M, Cseke G, Deflorian F, Jones CR, Mason JS, O'Brien MA, Ott GR, Pickworth M, Southall SM. Bucknell SJ, et al. Among authors: ator ma. J Med Chem. 2020 Jul 23;63(14):7906-7920. doi: 10.1021/acs.jmedchem.0c01003. Epub 2020 Jul 8. J Med Chem. 2020. PMID: 32558564
Novel poly(ADP-ribose) polymerase-1 inhibitors.
Dunn D, Husten J, Ator MA, Chatterjee S. Dunn D, et al. Among authors: ator ma. Bioorg Med Chem Lett. 2007 Jan 15;17(2):542-5. doi: 10.1016/j.bmcl.2006.10.010. Epub 2006 Oct 10. Bioorg Med Chem Lett. 2007. PMID: 17074482
Serendipity in discovery of proteasome inhibitors.
Dunn D, Iqbal M, Husten J, Ator MA, Chatterjee S. Dunn D, et al. Among authors: ator ma. Bioorg Med Chem Lett. 2012 May 15;22(10):3503-5. doi: 10.1016/j.bmcl.2012.03.086. Epub 2012 Mar 29. Bioorg Med Chem Lett. 2012. PMID: 22503349
3-(1'-Cyclobutylspiro[4H-1,3-benzodioxine-2,4'-piperidine]-6-yl)-5,5-dimethyl-1,4-dihydropyridazin-6-one (CEP-32215), a new wake-promoting histamine H3 antagonist/inverse agonist.
Hudkins RL, Gruner JA, Raddatz R, Mathiasen JR, Aimone LD, Marino MJ, Bacon ER, Williams M, Ator MA. Hudkins RL, et al. Among authors: ator ma. Neuropharmacology. 2016 Jul;106:37-45. doi: 10.1016/j.neuropharm.2015.09.025. Epub 2015 Sep 21. Neuropharmacology. 2016. PMID: 26400408
Piperidine-3,4-diol and piperidine-3-ol derivatives of pyrrolo[2,1-f][1,2,4]triazine as inhibitors of anaplastic lymphoma kinase.
Mesaros EF, Angeles TS, Albom MS, Wagner JC, Aimone LD, Wan W, Lu L, Huang Z, Olsen M, Kordwitz E, Haltiwanger RC, Landis AJ, Cheng M, Ruggeri BA, Ator MA, Dorsey BD, Ott GR. Mesaros EF, et al. Among authors: ator ma. Bioorg Med Chem Lett. 2015 Mar 1;25(5):1047-52. doi: 10.1016/j.bmcl.2015.01.019. Epub 2015 Jan 17. Bioorg Med Chem Lett. 2015. PMID: 25655723
Laquinimod arrests experimental autoimmune encephalomyelitis by activating the aryl hydrocarbon receptor.
Kaye J, Piryatinsky V, Birnberg T, Hingaly T, Raymond E, Kashi R, Amit-Romach E, Caballero IS, Towfic F, Ator MA, Rubinstein E, Laifenfeld D, Orbach A, Shinar D, Marantz Y, Grossman I, Knappertz V, Hayden MR, Laufer R. Kaye J, et al. Among authors: ator ma. Proc Natl Acad Sci U S A. 2016 Oct 11;113(41):E6145-E6152. doi: 10.1073/pnas.1607843113. Epub 2016 Sep 26. Proc Natl Acad Sci U S A. 2016. PMID: 27671624 Free PMC article.
Wake-promoting agents: search for next generation modafinil: part II.
Dunn D, Hostetler G, Iqbal M, Messina-McLaughlin P, Reiboldt A, Lin YG, Gruner J, Bacon ER, Ator MA, Chatterjee S. Dunn D, et al. Among authors: ator ma. Bioorg Med Chem Lett. 2012 Mar 15;22(6):2315-7. doi: 10.1016/j.bmcl.2012.01.064. Epub 2012 Jan 28. Bioorg Med Chem Lett. 2012. PMID: 22341942
Overview of drug discovery and development.
Ator MA, Mallamo JP, Williams M. Ator MA, et al. Curr Protoc Pharmacol. 2006 Dec;Chapter 9:Unit9.9. doi: 10.1002/0471141755.ph0909s35. Curr Protoc Pharmacol. 2006. PMID: 22294181
87 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page